Back to Search Start Over

Health-Related Quality of Life in Patients with Eosinophilic Esophagitis.

Authors :
van Klink ML
Bredenoord AJ
Source :
Immunology and allergy clinics of North America [Immunol Allergy Clin North Am] 2024 May; Vol. 44 (2), pp. 265-280. Date of Electronic Publication: 2024 Feb 07.
Publication Year :
2024

Abstract

Measuring health-related quality of life (HRQOL) gained relevance in research and clinical practice in patients with eosinophilic esophagitis. The physical discomfort and social and psychological consequences of this food-related disease substantially affect HRQOL. Determinant of an impaired HRQOL include symptom severity, disease duration, biological disease activity, and psychological factors. Patients prioritize symptom relief and improved HRQOL as treatment objectives. Available treatment options can address these goals; however, there is a suboptimal adherence to treatment. There is a need for enhanced patient guidance and education. The assessment of HRQOL will help to prioritize patient's needs in management.<br />Competing Interests: Disclosure No sources of funding were used to conduct this study or to prepare this article. M.L. van Klink has no conflicts of interest that are directly relevant to the content of this article, A.J. Bredenoord has received research funding from Nutricia, United States, Norgine, Netherlands, Thelial, Sanofi, United States/Regeneron, SST, and Dr Falk Pharma and received speaker and/or consulting fees from Laborie, Medtronic, Dr Falk Pharma, Calypso Biotech, Eupraxia, Aqilion, Alimentiv, Sanofi/Regeneron, Reckitt and AstraZeneca. A.J. Bredenoord is supported by Vidi grant 91718300 from the Netherlands Organisation for Scientific Research NWO.<br /> (Copyright © 2024 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1557-8607
Volume :
44
Issue :
2
Database :
MEDLINE
Journal :
Immunology and allergy clinics of North America
Publication Type :
Academic Journal
Accession number :
38575222
Full Text :
https://doi.org/10.1016/j.iac.2023.12.011